Do Treatment Sequencing / Pathways Models Have a Place in Health Technology Assessment?
That is the title of an ISPOR Europe panel I saw with Hugo Pedder, Jeroen Jansen, Dawn Lee and Mark Harries. The goal of sequential pathways model is to be able to answers questions like (i) how does a new treatment impact the cost and effectiveness for patients within a sequence of treatment, or (ii)…